{"id":34529,"date":"2026-03-18T15:50:55","date_gmt":"2026-03-18T15:50:55","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/34529\/"},"modified":"2026-03-18T15:50:55","modified_gmt":"2026-03-18T15:50:55","slug":"mankind-pharma-clinches-exclusive-rights-to-roches-rivotril-for-epilepsy-in-india-etpharma","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/34529\/","title":{"rendered":"Mankind Pharma Clinches Exclusive Rights to Roche&#8217;s Rivotril for Epilepsy in India, ETPharma"},"content":{"rendered":"<p>                                        <img fetchpriority=\"high\" decoding=\"async\" width=\"590\" height=\"442\" class=\"unveil\" loading=\"eager\" style=\"width:100%;max-height:100%\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/03\/129649145.cms.jpeg\" captionrendered=\"1\" alt=\"\"\/> New Delhi: <a id=\"30837700\" type=\"Denny\" weightage=\"20\" keywordseo=\"Mankind-Pharma\" source=\"keywords\" class=\"news-keywords\" href=\"https:\/\/pharma.economictimes.indiatimes.com\/tag\/mankind+pharma\" rel=\"nofollow noopener\" target=\"_blank\">Mankind Pharma<\/a> has secured exclusive rights to market Swiss pharma major <a id=\"31436938\" type=\"Denny\" weightage=\"20\" keywordseo=\"Roche\" source=\"keywords\" class=\"news-keywords\" href=\"https:\/\/pharma.economictimes.indiatimes.com\/tag\/roche\" rel=\"nofollow noopener\" target=\"_blank\">Roche<\/a>\u2019s <a id=\"32627690\" type=\"Denny\" weightage=\"20\" keywordseo=\"epilepsy-drug\" source=\"keywords\" class=\"news-keywords\" href=\"https:\/\/pharma.economictimes.indiatimes.com\/tag\/epilepsy+drug\" rel=\"nofollow noopener\" target=\"_blank\">epilepsy drug<\/a> <a id=\"34246103\" type=\"Denny\" weightage=\"20\" keywordseo=\"Rivotril\" source=\"keywords\" class=\"news-keywords\" href=\"https:\/\/pharma.economictimes.indiatimes.com\/tag\/rivotril\" rel=\"nofollow noopener\" target=\"_blank\">Rivotril<\/a> in India. <\/p>\n<p>Under the agreement, in exchange of an undisclosed amount, the Delhi-based drugmaker has obtained rights manufacture, market and distribute the product across the country.<\/p>\n<p><a href=\"https:\/\/pharma.economictimes.indiatimes.com\/tag\/rivotril\" rel=\"nofollow noopener\" target=\"_blank\">Rivotril<\/a> (<a id=\"29644248\" type=\"Denny\" weightage=\"20\" keywordseo=\"clonazepam\" source=\"keywords\" class=\"news-keywords\" href=\"https:\/\/pharma.economictimes.indiatimes.com\/tag\/clonazepam\" rel=\"nofollow noopener\" target=\"_blank\">clonazepam<\/a>) is widely prescribed for managing neurological and psychiatric conditions, such as seizure disorders, including epilepsy, Lennox-Gastaut syndrome, and myoclonic seizures. <\/p>\n<p>Chronic therapies now account for a rising share of Mankind\u2019s overall business and the latest acquisition is stated to \u201ccomplements its existing neuro portfolio.\u201d  <\/p>\n<p>\u201cThis acquisition is aligned with our strategic focus on strengthening our presence in chronic and specialty therapies,\u201d said Atish Majumdar, Senior President, Sales and Marketing, <a href=\"https:\/\/pharma.economictimes.indiatimes.com\/tag\/mankind+pharma\" rel=\"nofollow noopener\" target=\"_blank\">Mankind Pharma<\/a> Specialty Business. <\/p>\n<p>\u201cLeveraging our large field force and nationwide distribution network, we are well positioned to build the brand and support physicians in delivering better outcomes for patients across India,\u201d he added.\n                                                                    <\/p>\n<p>                                    Published On Mar 18, 2026 at 12:02 PM IST<\/p>\n<p>\n                Join the community of 2M+ industry professionals.<br \/>\n                Subscribe to Newsletter to get latest insights &amp; analysis in your inbox.\n            <\/p>\n<p>                    All about ETPharma industry right on your smartphone! <\/p>\n<p>                        <img decoding=\"async\" loading=\"lazy\" width=\"90\" height=\"90\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/03\/1773849055_999_pharma_barcode.png\" alt=\"\"\/>                        <\/p>\n","protected":false},"excerpt":{"rendered":"New Delhi: Mankind Pharma has secured exclusive rights to market Swiss pharma major Roche\u2019s epilepsy drug Rivotril in&hellip;\n","protected":false},"author":2,"featured_media":34530,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[124],"tags":[20427,20426,20302,20313,134],"class_list":{"0":"post-34529","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-roche","8":"tag-clonazepam","9":"tag-epilepsy-drug","10":"tag-mankind-pharma","11":"tag-rivotril","12":"tag-roche"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116250980029360885","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/34529","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=34529"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/34529\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/34530"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=34529"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=34529"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=34529"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}